BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30027909)

  • 1. Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models.
    Sarkar S
    J Genet; 2018 Jul; 97(3):783-793. PubMed ID: 30027909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted downregulation of dMyc restricts neurofibrillary tangles mediated pathogenesis of human neuronal tauopathies in Drosophila.
    Chanu SI; Sarkar S
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2111-2119. PubMed ID: 28529046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
    Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
    Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Lewis J; Dickson DW
    Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
    Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
    Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Proteostasis in Neurodegenerative Tauopathies.
    Papanikolopoulou K; Skoulakis EMC
    Adv Exp Med Biol; 2020; 1233():177-194. PubMed ID: 32274757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropathology of tauopathy].
    Yoshida M
    Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo.
    Kuchibhotla KV; Wegmann S; Kopeikina KJ; Hawkes J; Rudinskiy N; Andermann ML; Spires-Jones TL; Bacskai BJ; Hyman BT
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):510-4. PubMed ID: 24368848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial fibrillary tangles and JAK/STAT-mediated glial and neuronal cell death in a Drosophila model of glial tauopathy.
    Colodner KJ; Feany MB
    J Neurosci; 2010 Dec; 30(48):16102-13. PubMed ID: 21123557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies.
    Arima K
    Neuropathology; 2006 Oct; 26(5):475-83. PubMed ID: 17080728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
    Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
    Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].
    Sánchez MP; Alvarez-Tallada V; Avila J
    Rev Neurol; 2001 Jul 16-31; 33(2):169-77. PubMed ID: 11562878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation.
    Chanu SI; Sarkar S
    Mol Neurobiol; 2017 May; 54(4):2706-2719. PubMed ID: 27000837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tauopathies: recent insights into old diseases.
    Delacourte A
    Folia Neuropathol; 2005; 43(4):244-57. PubMed ID: 16416389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies.
    Ubhi KK; Shaibah H; Newman TA; Shepherd D; Mudher A
    Invert Neurosci; 2007 Sep; 7(3):165-71. PubMed ID: 17636367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
    Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
    J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.